PerkinElmer to Present at Morgan Stanley Global Healthcare Conference
Aug. 23, 2018
WALTHAM, Mass.--(BUSINESS WIRE)--Aug 23, 2018--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 16 th annual Morgan Stanley Global Healthcare Conference on Friday, September 14, 2018 at 11:40 a.m. ET at the Grand Hyatt New York in New York City.
Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities.
A live audio webcast of the presentation will also be available on the Investor s section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.
About PerkinElmer PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005094/en/
CONTACT: PerkinElmer, Inc.
Tommy J. Thomas, 781-663-5889
Brian Willinsky, 781-663-5728
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL
SOURCE: PerkinElmer, Inc.
Copyright Business Wire 2018.
PUB: 08/23/2018 04:15 PM/DISC: 08/23/2018 04:15 PM